Junping Zhang

8.1k total citations
229 papers, 5.5k citations indexed

About

Junping Zhang is a scholar working on Molecular Biology, Cancer Research and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Junping Zhang has authored 229 papers receiving a total of 5.5k indexed citations (citations by other indexed papers that have themselves been cited), including 103 papers in Molecular Biology, 43 papers in Cancer Research and 36 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Junping Zhang's work include MicroRNA in disease regulation (17 papers), Cancer-related molecular mechanisms research (15 papers) and Cardiac Fibrosis and Remodeling (13 papers). Junping Zhang is often cited by papers focused on MicroRNA in disease regulation (17 papers), Cancer-related molecular mechanisms research (15 papers) and Cardiac Fibrosis and Remodeling (13 papers). Junping Zhang collaborates with scholars based in China, United States and United Kingdom. Junping Zhang's co-authors include Shixin Xu, Ao Zhang, Shichao Lv, Zhongwen Qi, Qiujin Jia, Wei‐Fen Xie, Zhenlin Hu, Meng Li, Chuan Yin and Xiaodong Zhang and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Journal of the American College of Cardiology.

In The Last Decade

Junping Zhang

213 papers receiving 5.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Junping Zhang China	45	3.0k	1.2k	845	679	544	229	5.5k
Fei Wang China	41	3.5k 1.1×	2.4k 2.0×	1.1k 1.3×	513 0.8×	297 0.5×	313	6.6k
Rongxin Zhang China	44	3.1k 1.0×	1.5k 1.2×	713 0.8×	1.3k 2.0×	231 0.4×	242	6.3k
Weiping Chen China	42	3.2k 1.1×	780 0.6×	1.1k 1.2×	660 1.0×	266 0.5×	191	6.5k
Keun‐Gyu Park South Korea	47	3.1k 1.0×	1.1k 0.9×	1.4k 1.6×	700 1.0×	292 0.5×	140	6.7k
Xu Han China	42	2.2k 0.7×	610 0.5×	935 1.1×	382 0.6×	205 0.4×	278	5.0k
Tian Lan China	38	2.3k 0.8×	892 0.7×	920 1.1×	630 0.9×	565 1.0×	134	4.5k
Qi Chen China	38	2.5k 0.8×	1.0k 0.9×	683 0.8×	620 0.9×	133 0.2×	144	5.1k
Hideaki Kamata Japan	34	4.1k 1.4×	1.2k 1.0×	967 1.1×	1.4k 2.0×	326 0.6×	71	6.8k
Ke Chen China	44	4.1k 1.4×	2.1k 1.7×	867 1.0×	631 0.9×	162 0.3×	213	6.6k

Countries citing papers authored by Junping Zhang

Since Specialization

Citations

This map shows the geographic impact of Junping Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junping Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junping Zhang more than expected).

Fields of papers citing papers by Junping Zhang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junping Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junping Zhang. The network helps show where Junping Zhang may publish in the future.

Co-authorship network of co-authors of Junping Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Junping Zhang. A scholar is included among the top collaborators of Junping Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junping Zhang. Junping Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yu, Hong, Wenbing Liu, Junping Zhang, et al.. (2025). The Clinical and Molecular Characterization of Distinct Subtypes in Adult T Cell Acute Lymphoblastic Leukemia. Cancer Science. 116(4). 1126–1138.

Fan, Mengni, Barbara A. Konkle, Marilyn J. Manco‐Johnson, et al.. (2025). Exploration of biomarkers for inhibitor development in persons with hemophilia A. Research and Practice in Thrombosis and Haemostasis. 9(4). 102877–102877. 1 indexed citations

Zhu, Ruiqi, Chunhong Zhang, Lien Zhu, et al.. (2024). Porous hierarchical Mxene/chitosan cryogel with synergistic phosphate/amidoxime groups for ultra-efficient uranium adsorption under pH-response behavior. Chemical Engineering Journal. 504. 158181–158181. 16 indexed citations

Qi, Zhongwen, et al.. (2024). The mechanism and promising therapeutic strategy of diabetic cardiomyopathy dysfunctions: Focus on pyroptosis. Journal of Diabetes and its Complications. 38(10). 108848–108848. 4 indexed citations

Liu, Wenbing, Hui Wei, Ying Wang, et al.. (2024). The RTK–RAS signaling pathway is enriched in patients with rare acute myeloid leukemia harboring t(16;21)(p11;q22)/FUS::ERG. SHILAP Revista de lepidopterología. 6(2). e00188–e00188. 2 indexed citations

Yan, Zhipeng, et al.. (2024). Primordial Drivers of Diabetes Heart Disease: Comprehensive Insights into Insulin Resistance. Diabetes & Metabolism Journal. 48(1). 19–36. 21 indexed citations

Zhang, Junping, Chunyu Xiong, Na Zhang, et al.. (2023). Achieving high-performance peptide-based foam via moderate hydrolysis and zinc coordination of oat proteins. Food Hydrocolloids. 150. 109685–109685. 8 indexed citations

Feng, Huijing, Guo‐Bin Ding, Cihui Yan, et al.. (2023). TP53 Exon 5 Mutation Indicates Poor Progression-Free Survival for Patients with Stage IV NSCLC. Frontiers in Bioscience-Landmark. 28(7). 147–147. 3 indexed citations

Li, Aolin, et al.. (2023). The role of mitochondria in myocardial damage caused by energy metabolism disorders: From mechanisms to therapeutics. Free Radical Biology and Medicine. 208. 236–251. 46 indexed citations

10.

Lv, Shichao, et al.. (2021). QiShenYiQi Pill Improves Myocardial Hypertrophy Caused by Pressure Overload in Rats. Evidence-based Complementary and Alternative Medicine. 2021. 1–10. 4 indexed citations

11.

Shi, Jie, Zhiyu Wang, Junping Zhang, et al.. (2021). Genomic Landscape and Tumor Mutational Burden Determination of Circulating Tumor DNA in Over 5,000 Chinese Patients with Lung Cancer. Clinical Cancer Research. 27(22). 6184–6196. 9 indexed citations

12.

Liu, Hailong, Youliang Sun, Qian Zhang, et al.. (2021). Pro-inflammatory and proliferative microglia drive progression of glioblastoma. Cell Reports. 36(11). 109718–109718. 100 indexed citations

13.

Lv, Shichao, Peng Yuan, Meng Li, et al.. (2020). QiShenYiQi pill improves the reparative myocardial fibrosis by regulating autophagy. Journal of Cellular and Molecular Medicine. 24(19). 11283–11293. 14 indexed citations

14.

Bai, Xiaodan, et al.. (2020). Proinflammatory and Anti-inflammatory Genes in Stroke Pathogenesis. Current Pharmaceutical Design. 26(34). 4220–4233. 7 indexed citations

15.

Zhang, Junping, et al.. (2019). ER Stress Activates the NLRP3 Inflammasome: A Novel Mechanism of Atherosclerosis. Oxidative Medicine and Cellular Longevity. 2019. 1–18. 114 indexed citations

16.

Zhang, Junping. (2013). Study on the effects of Simiao Yong An Decoction on the vascular smooth muscle cell migration. Zhonghua zhongyiyao zazhi. 3 indexed citations

17.

Zhang, Junping. (2011). Diagnostic Value of Cardiac MRI for Viral Myocarditis: A Systematic Review. Zhongguo xunzheng yixue zazhi. 1 indexed citations

18.

Ning, Beifang, Jin Ding, Chuan Yin, et al.. (2010). Hepatocyte Nuclear Factor 4α Suppresses the Development of Hepatocellular Carcinoma. Cancer Research. 70(19). 7640–7651. 194 indexed citations

19.

Zhang, Junping. (2010). To Explore the Change Rule of Wind-phlegm Syndrome of Ischemic Stroke. Zhonghua zhongyiyao xuekan. 1 indexed citations

20.

Zhang, Junping. (2008). Discussion on apoplexy mechanism based on theoty of phlegm and stagant blood converting into toxicity. Tianjin Journal of Traditional Chinese Medicine. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact